AI assistant
Gossamer Bio, Inc. — Director's Dealing 2021
Apr 20, 2021
32603_dirs_2021-04-20_96c17c24-3cd4-477b-87b7-4d944ac74056.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2021-04-16
Reporting Person: Peterson Caryn (EVP, Regulatory Affairs)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 64008 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.61 | 2028-05-21 | Common Stock (86444.0) | Direct | |
| Stock Option (Right to Buy) | $10.71 | 2028-12-10 | Common Stock (48888.0) | Direct | |
| Stock Option (Right to Buy) | $22.1 | 2029-03-25 | Common Stock (48500.0) | Direct | |
| Stock Option (Right to Buy) | $16.4 | 2029-12-23 | Common Stock (13750.0) | Direct | |
| Stock Option (Right to Buy) | $14.55 | 2030-02-14 | Common Stock (34175.0) | Direct | |
| Stock Option (Right to Buy) | $9.79 | 2031-02-25 | Common Stock (28250.0) | Direct |
Footnotes
F1: Includes 54,427 restricted stock unit awards, which will vest in accordance with the terms of each award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.
F2: 64,840 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on April 21, 2021 and the last day of each one-month period thereafter through May 21, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F3: 28,540 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on May 10, 2021 and the last day of each one-month period thereafter through December 10, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F4: 24,250 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on April 25, 2021 and the last day of each one-month period thereafter through March 25, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F5: 4,296 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on April 23, 2021 and the last day of each one-month period thereafter through December 23, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F6: 9,967 shares subject to the option have vested and are fully exerciseable and 1/48th of the total number of shares subject to the option vest on May 14, 2021 and the last day of each one-month period thereafter through February 14, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F7: 25% of the total number of shares subject to the option will vest on February 25, 2022 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.